|
ASCO over--reports to follow--sorry for the "silence" (computer in the shop 4 fixing)
One of the most interesting talks was given on the last day and speaker was from MDAnderson. They took Stage IVs who were heavily pretreated from various solid cancers and treated them either with
Avastin+sunitib
Avastin+sorafinib
Avastin+herceptin+lapatinib
Avastin+cefituximab+ erlotinib
Four VERY expensive arms
her2+ bc treated with the third arm did remarkably well considering how much pretreatment the patients had. Will pull out my notes and post later
There was also a poster by Martine Piccart et al on a subset of her2+ bc which was ER+ with a prognosis worse than triple negative. Noone represented the poster, so not able to ask questions. Will seek answers elsewhere.
Still trying to get over the meeting (exhausting), catch up with things I got behind on while computer fixed and get situated.
|